Can Tenet Healthcare Beat Q3 Earnings on Ambulatory Care Strength?

Tenet Healthcare (THC) heads into Q3 2026 earnings with a quantified beat setup: consensus calls for $4.60 per share, up 24.3% year over year, on revenue of $5.47 billion, up 3.5%.

The Ambulatory Care segment is the expected growth engine. Estimates call for an 8.4% revenue increase and 9.3% adjusted EBITDA growth. That gap between 8.4% top-line growth and 9.3% EBITDA growth suggests margin expansion in the segment, which is our interpretation of the figures, not a company statement.

The hospital side is softer. Hospital patient days may fall 3.7%, and increased utilization costs could partially offset the ambulatory gains. Consensus revenue growth of just 3.5% against 24.3% EPS growth shows how much of the expected earnings lift depends on mix and margin rather than volume.

The quantitative signals lean positive. THC carries an Earnings ESP of +11.11%, meaning the most accurate analyst estimate sits above consensus, and a Zacks Rank #3 (Hold). Zacks says the combination points to a likely beat.